2m 2m 2m 2m 2m 2m 2m
Oramed (ORMP)
NASDAQ
$4.11-$0.06 (-1.56%)
Price as of Jun 23, 2026 7:02 PM EDT- $164.1MMarket Cap
- 103.86%1-Year Change
- BiotechnologyIndustry
Oramed (ORMP)
$4.11-$0.06 (-1.56%)
ORMP | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.17 | ||
Change | +$0.16 (+3.99%) | ||
Open | $3.97 | ||
High | $4.20 | ||
Low | $3.96 | ||
Previous Close | $4.01 | ||
Volume | 366,117 | ||
30-Day Average Volume | 204,945 | ||
1-Week Change | 10.61% | ||
1-Month Change | 4.51% | ||
1-Year Change | 106.13% | ||
3-Year Change | 37.63% | ||
5-Year Change | -68.23% | ||
Fundamentals | |||
Shares Outstanding | 40.9M | ||
Total Assets | $268.8M | ||
Market Cap | $164.1M | ||
Enterprise Value | $164.2M | ||
Period: QTR TTM FY | |||
Revenue | $36.5M | ||
Net Income | $38.3M | ||
Free Cash Flow | -$2.9M | ||
EBIT | $49.4M | ||
EBITDA | $49.5M | ||
Net Working Capital | $57.6M | ||
EPS | $0.91 | ||
Enterprise Value/EBITDA | 3 | ||
Enterprise Value/Revenue | 4 | ||
P/B | 1 | ||
P/E | 4 | ||
PEG | 0 | ||
Price/Free Cash Flow | -56 | ||
Price/Operating Cash Flow | -56 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 53.96% | ||
Trailing Annual Dividend Yield | 6.00% | ||
Ex-Dividend Date | 01/16/2026 | ||
Last Split Factor | 1 : 12 | ||
Last Split Date | 01/23/2013 | ||
Earnings & Revenue
Annual Dividend Yield